Healthcare Q4 Earnings Preview - Domestic Growth To Be Moderated By Subdued U.S.: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Our healthcare universe (12 coverage companies) is expected to post decent YoY growth of approximately 7% to ~Rs 43930 crore led by continued chronic traction in the domestic market partly offset by a decline in U.S. formulations amid lack of meaningful new launches and a weak flu season.
Domestic growth is expected to be led by a partial recovery in the acute segment, reasonable traction in the chronic segment and Covid-19 related product sales.
U.S. formulations are expected to remain subdued amid lack of new launches and waning currency tailwinds from preceding quarters.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.